Expression of the chemokine receptor cxcr3 and its ligand ip-10 during human cardiac allograft rejection

Circulation

Volumn 104, Issue 21, 2001, Pages 2558-2564

  Melter, Michael ^a,b   Exeni, Andrea ^a,b   Reinders, Marlies E J ^a,b   Fang, James C ^c   McMahon, Gearoid ^a,b   Ganz, Peter ^c   Hancock, Wayne W ^d   Briscoe, David M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Chemokine; Rejection; Transplantation

Indexed keywords

CD3 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; EOTAXIN; LIGAND; LYMPHOTACTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

EID: 0035923631     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4601.098010     Document Type: Article

References (22)

1. Lymphocyte traffic control by chemokines
2. International union of pharmacology, XXII: Nomenclature for chemokine receptors
3. Current understanding of chemokine involvement in allograft transplantation
4. Chemokines and their receptors in allograft rejection
5. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
6. Requirement of the chemokine receptor CXCR3 for acute allograft rejection
7. Donor-derived IP-10 initiates development of acute allograft rejection
8. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group: The International Society for Heart Transplantation
9. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant
10. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts
11. CD40 and CD40 ligand (CD154) are co-expressed on microvessels in vivo in human cardiac allograft rejection
12. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
13. The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection
14. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
15. Activation of dual T cell signaling pathways by the chemokine RANTES
16. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection
17. CCR1-specific non-peptide antagonist: Efficacy in a rabbit allograft rejection model
18. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
19. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation
20. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
21. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts
22. Beneficial effects of targeting CCR5 in allograft recipients